Roundtable Discussion: Managing Complications in a High-Risk, Low-Volume Population to Improve Long-Term Outcomes in Kidney Transplant Patients

• Exploring the clinical burden and heterogeneity of post-transplant complications, including chronic rejection, delayed graft function, and viral infections
• Examining the challenges and opportunities in developing therapies and generating evidence in small, high-risk patient groups
• Identifying how trial design, biomarkers, and real-world data can support better outcomes

Speakers:

Nitender Goyal

Senior Director Clinical Research

Alnylam Pharmaceuticals